Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
1.110
0.00 (0.00%)
Jul 22, 2024, 9:56 AM EDT - Market open
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,052,401
Market Cap
1.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Assure Holdings | 95 |
China SXT Pharmaceuticals | 78 |
LogicMark | 27 |
Seelos Therapeutics | 16 |
Bluejay Diagnostics | 10 |
SCWorx | 9 |
Dermata Therapeutics | 8 |
GRI Bio | 4 |
BBLG News
- 4 weeks ago - First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion - Business Wire
- 4 months ago - Bone Biologics Announces Closing of $2.0 Million Public Offering - Business Wire
- 5 months ago - Bone Biologics Announces Pricing of $2.0 Million Public Offering - Business Wire
- 5 months ago - Bone Biologics Reports Progress With NB1 Clinical Program - Business Wire
- 6 months ago - Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors - Business Wire
- 6 months ago - Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements - Business Wire
- 7 months ago - Bone Biologics Announces 1-for-8 Reverse Stock Split - Business Wire
- 8 months ago - Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Business Wire